| 1 | Ehlers-danlos syndrome, classic type, 1 | Enrichment | COL1A1, COL1A2, COL5A1, COL5A2 | 8.68 |
| 2 | Classic ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2, COL5A1, COL5A2 | 8.68 |
| 3 | Ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2, COL3A1, COL5A1, COL5A2 | 8.30 |
| 4 | Junctional epidermolysis bullosa | Enrichment | ITGA6, ITGB4, LAMA3, LAMB3, LAMC2 | 7.92 |
| 5 | Hereditary chronic pancreatitis | Enrichment | CFTR, CPA1, CTRC, PRSS1, SPINK1 | 7.81 |
| 6 | Pancreatitis, hereditary | Enrichment | CFTR, CPA1, CTRC, PRSS1, SPINK1 | 7.33 |
| 7 | Skin disease | Enrichment | FLG, ITGB4, KRT14, KRT17, LAMB3, LAMC2 | 7.21 |
| 8 | Maturity-onset diabetes of the young | Enrichment | CEL, HNF1B, PDX1, PTF1A | 6.92 |
| 9 | Epidermolysis bullosa, junctional 1a, intermediate | Enrichment | ITGB4, LAMA3, LAMB3, LAMC2 | 6.83 |
| 10 | Junctional epidermolysis bullosa non-herlitz type | Enrichment | ITGB4, LAMA3, LAMB3, LAMC2 | 6.83 |
| 11 | Epidermolysis bullosa, junctional 1b, severe | Enrichment | LAMA3, LAMB3, LAMC2 | 6.08 |
| 12 | Connective tissue disease | Enrichment | COL11A1, COL2A1, COL5A1, SOX9 | 5.34 |
| 13 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | ACTA2, COL1A1, COL3A1, COL5A1, COL5A2, MYH11 | 5.31 |
| 14 | Pancreas, dorsal, agenesis of | Enrichment | PDX1, PTF1A | 5.27 |
| 15 | Tropical calcific pancreatitis | Enrichment | CTRC, SPINK1 | 5.27 |
| 16 | Kallikrein, decreased urinary activity of | Enrichment | KLK1, PTF1A | 5.27 |
| 17 | Lung cancer susceptibility 3 | Enrichment | ACTA2, EGFR, ERBB2, FGF10 | 5.04 |
| 18 | Epidermolysis bullosa simplex 1c, localized | Enrichment | ITGB4, KRT14, KRT5 | 5.00 |
| 19 | Epidermolysis bullosa | Enrichment | ITGA6, KRT5, LAMB3 | 5.00 |
| 20 | Spondyloepimetaphyseal dysplasia, strudwick type | Enrichment | COL2A1, FN1 | 4.91 |
| 21 | Spondylometaphyseal dysplasia, corner fracture type | Enrichment | COL2A1, FN1 | 4.91 |
| 22 | Otospondylomegaepiphyseal dysplasia, autosomal recessive | Enrichment | COL11A2, COL2A1 | 4.91 |
| 23 | Otospondylomegaepiphyseal dysplasia, autosomal dominant | Enrichment | COL11A2, COL2A1 | 4.91 |
| 24 | Ehlers-danlos syndrome, arthrochalasia type, 2 | Enrichment | COL1A1, COL1A2 | 4.91 |
| 25 | Fibrochondrogenesis | Enrichment | COL11A1, COL11A2 | 4.91 |
| 26 | Stickler syndrome, type ii | Enrichment | COL11A1, COL1A1 | 4.91 |
| 27 | Ehlers-danlos/osteogenesis imperfecta syndrome | Enrichment | COL1A1, COL1A2 | 4.91 |
| 28 | Congenital heart defects, multiple types, 4 | Enrichment | GATA4, GATA6 | 4.78 |
| 29 | Heart, malformation of | Enrichment | COL11A2, COL2A1, GATA4 | 4.49 |
| 30 | Epidermolysis bullosa simplex | Enrichment | ITGB4, KRT14, KRT5 | 4.47 |
| 31 | Telecanthus | Enrichment | COL11A1, COL5A2 | 4.44 |
| 32 | Ehlers-danlos syndrome, classic type, 2 | Enrichment | COL5A1, COL5A2 | 4.44 |
| 33 | High bone mass osteogenesis imperfecta | Enrichment | COL1A1, COL1A2 | 4.44 |
| 34 | Ehlers-danlos syndrome, arthrochalasia type, 1 | Enrichment | COL1A1, COL1A2 | 4.14 |
| 35 | Osteogenesis imperfecta with normal sclerae, dominant form | Enrichment | COL1A1, COL1A2 | 4.14 |
| 36 | Epidermolysis bullosa simplex 1d, generalized, intermediate or severe, autosomal recessive | Enrichment | KRT14, KRT5 | 3.99 |
| 37 | 46,xy partial gonadal dysgenesis | Enrichment | GATA4, SOX9 | 3.82 |
| 38 | Osteogenesis imperfecta, type i | Enrichment | COL1A1, COL1A2 | 3.74 |
| 39 | Keratoconus | Enrichment | COL1A1, COL5A2 | 3.74 |
| 40 | Patent foramen ovale | Enrichment | GATA4, GATA6 | 3.60 |
| 41 | Osteogenesis imperfecta, type ii | Enrichment | COL1A1, COL1A2 | 3.59 |
| 42 | Diabetes mellitus | Enrichment | CELA2A, SPINK1 | 3.53 |
| 43 | Ichthyosis with confetti | Enrichment | KRT1, KRT10 | 3.52 |
| 44 | Ichthyosis, annular epidermolytic, 1 | Enrichment | KRT1, KRT10 | 3.52 |
| 45 | Annular epidermolytic ichthyosis | Enrichment | KRT1, KRT10 | 3.52 |
| 46 | Autosomal dominant epidermolytic ichthyosis | Enrichment | KRT1, KRT10 | 3.52 |
| 47 | Multiple sclerosis | Enrichment | ITGB4, LAMA5, LAMB1 | 3.47 |
| 48 | Aortic aneurysm, familial thoracic 1 | Enrichment | COL3A1, GATA4, MYH11 | 3.47 |
| 49 | Myopia | Enrichment | COL11A1, COL2A1, MYH11 | 3.38 |
| 50 | Familial atrial fibrillation | Enrichment | GATA4, GATA6 | 3.35 |
| 51 | Nephrotic syndrome | Enrichment | FN1, LAMA5, LAMB2 | 3.33 |
| 52 | Tetralogy of fallot | Enrichment | GATA4, GATA6 | 3.28 |
| 53 | Stickler syndrome | Enrichment | COL11A1, COL2A1 | 3.27 |
| 54 | Primary bone dysplasia | Enrichment | COL1A1, COL1A2 | 3.27 |
| 55 | Epidermolysis bullosa simplex 1b, generalized intermediate | Enrichment | KRT14, KRT5 | 3.22 |
| 56 | Epidermolysis bullosa simplex generalized type | Enrichment | KRT14, KRT5 | 3.22 |
| 57 | Epidermolytic hyperkeratosis | Enrichment | KRT1, KRT10 | 3.22 |
| 58 | Osteochondrodysplasia | Enrichment | COL1A1, COL1A2 | 3.18 |
| 59 | Osteogenesis imperfecta, type iv | Enrichment | COL1A1, COL1A2 | 3.03 |
| 60 | Epidermolysis bullosa simplex 2f, with mottled pigmentation | Enrichment | KRT14, KRT5 | 3.00 |
| 61 | Epidermolysis bullosa simplex 1a, generalized severe | Enrichment | KRT14, KRT5 | 3.00 |
| 62 | Epidermolytic hyperkeratosis 1 | Enrichment | KRT1, KRT10 | 3.00 |
| 63 | Osteoporosis | Enrichment | COL1A1, COL1A2 | 2.96 |
| 64 | Osteogenesis imperfecta, type iii | Enrichment | COL1A1, COL1A2 | 2.90 |
| 65 | Holoprosencephaly 3 | Enrichment | SHH | 2.88 |
| 66 | Pancreatic agenesis 1 | Enrichment | PDX1 | 2.88 |
| 67 | Maturity-onset diabetes of the young, type 4 | Enrichment | PDX1 | 2.88 |
| 68 | Hypomagnesemia 4, renal | Enrichment | EGF | 2.88 |
| 69 | Microphthalmia/coloboma 5 | Enrichment | SHH | 2.88 |
| 70 | Prostate cancer, hereditary, 11 | Enrichment | HNF1B | 2.88 |
| 71 | Vesicoureteral reflux 3 | Enrichment | SOX17 | 2.88 |
| 72 | Whim syndrome 1 | Enrichment | CXCR4 | 2.88 |
| 73 | Atrioventricular septal defect 4 | Enrichment | GATA4 | 2.88 |
| 74 | Atrioventricular septal defect 5 | Enrichment | GATA6 | 2.88 |
| 75 | Aplasia of lacrimal and salivary glands | Enrichment | FGF10 | 2.88 |
| 76 | 46,xy sex reversal 10 | Enrichment | SOX9 | 2.88 |
| 77 | 46,xx sex reversal 2 | Enrichment | SOX9 | 2.88 |
| 78 | Lacrimoauriculodentodigital syndrome 3 | Enrichment | FGF10 | 2.88 |
| 79 | Atrial septal defect 2 | Enrichment | GATA4 | 2.88 |
| 80 | Testicular anomalies with or without congenital heart disease | Enrichment | GATA4 | 2.88 |
| 81 | Atrial septal defect 9 | Enrichment | GATA6 | 2.88 |
| 82 | 8p23.1 microdeletion syndrome | Enrichment | GATA4 | 2.88 |
| 83 | Short-rib thoracic dysplasia 22 without polydactyly | Enrichment | FGF4 | 2.88 |
| 84 | Pulmonary hypertension, primary, 7 | Enrichment | SOX17 | 2.88 |
| 85 | Non-acquired combined pituitary hormone deficiency | Enrichment | FOXA2 | 2.88 |
| 86 | Partial atrioventricular septal defect with ventricular hypoplasia | Enrichment | GATA4 | 2.88 |
| 87 | Medullary sponge kidney | Enrichment | HNF1B | 2.88 |
| 88 | Renal dysplasia, bilateral | Enrichment | HNF1B | 2.88 |
| 89 | Unilateral multicystic dysplastic kidney | Enrichment | HNF1B | 2.88 |
| 90 | Renal dysplasia, unilateral | Enrichment | HNF1B | 2.88 |
| 91 | Egf-related primary hypomagnesemia with intellectual disability | Enrichment | EGF | 2.88 |
| 92 | Interstitial lung disease specific to childhood | Enrichment | FGF10 | 2.88 |
| 93 | Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome | Enrichment | SHH | 2.88 |
| 94 | Type 2 diabetes mellitus | Enrichment | HNF1B, PDX1 | 2.86 |
| 95 | Epidermolysis bullosa, junctional 5b, with pyloric atresia | Enrichment | ITGA6, ITGB4 | 2.83 |
| 96 | Maturity-onset diabetes of the young, type 8, with exocrine dysfunction | Enrichment | CEL | 2.63 |
| 97 | Pancreatic and cerebellar agenesis | Enrichment | PTF1A | 2.63 |
| 98 | Abdominal obesity-metabolic syndrome 4 | Enrichment | CELA2A | 2.63 |
| 99 | Pancreatic lipase deficiency | Enrichment | PNLIP | 2.63 |
| 100 | Pancreatic triacylglycerol lipase deficiency | Enrichment | PNLIP | 2.63 |
| 101 | Tubulointerstitial kidney disease, autosomal dominant 1 | Enrichment | HNF1B | 2.58 |
| 102 | Renal cysts and diabetes syndrome | Enrichment | HNF1B | 2.58 |
| 103 | Congenital anomalies of kidney and urinary tract 2 | Enrichment | HNF1B | 2.58 |
| 104 | Campomelic dysplasia | Enrichment | SOX9 | 2.58 |
| 105 | Pulmonary hypoplasia, primary | Enrichment | FGF10 | 2.58 |
| 106 | Solitary median maxillary central incisor | Enrichment | SHH | 2.58 |
| 107 | Neutropenia, severe congenital, 8, autosomal dominant | Enrichment | GATA6 | 2.58 |
| 108 | Hyperuricemic nephropathy, familial juvenile, 3 | Enrichment | HNF1B | 2.58 |
| 109 | 46,xy sex reversal 3 | Enrichment | GATA4 | 2.58 |
| 110 | Isolated radial hemimelia | Enrichment | SHH | 2.58 |
| 111 | Campomelic dysplasia and related disorders | Enrichment | SOX9 | 2.58 |
| 112 | Erythrokeratodermia variabilis et progressiva 1 | Enrichment | GJB3, LORICRIN | 2.56 |
| 113 | Brittle bone disorder | Enrichment | COL1A1, COL1A2 | 2.53 |
| 114 | Familial thoracic aortic aneurysm and dissection | Enrichment | COL3A1, MYH11 | 2.46 |
| 115 | Stickler syndrome, type i | Enrichment | COL2A1 | 2.45 |
| 116 | Pachyonychia congenita 2 | Enrichment | KRT17 | 2.45 |
| 117 | Epiphyseal dysplasia, multiple, with myopia and conductive deafness | Enrichment | COL2A1 | 2.45 |
| 118 | Ehlers-danlos syndrome, cardiac valvular type | Enrichment | COL1A2 | 2.45 |
| 119 | Spondylometaphyseal dysplasia, algerian type | Enrichment | COL2A1 | 2.45 |
| 120 | Deafness, autosomal recessive 53 | Enrichment | COL11A2 | 2.45 |
| 121 | Osteoarthritis with mild chondrodysplasia | Enrichment | COL2A1 | 2.45 |
| 122 | Avascular necrosis of femoral head, primary, 1 | Enrichment | COL2A1 | 2.45 |
| 123 | Czech dysplasia | Enrichment | COL2A1 | 2.45 |
| 124 | Stargardt disease 4 | Enrichment | PROM1 | 2.45 |
| 125 | Marshall syndrome | Enrichment | COL11A1 | 2.45 |
| 126 | Kniest dysplasia | Enrichment | COL2A1 | 2.45 |
| 127 | Cardiomyopathy, dilated, 1jj | Enrichment | LAMA4 | 2.45 |
| 128 | Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development | Enrichment | YAP1 | 2.45 |
| 129 | Platyspondylic lethal skeletal dysplasia, torrance type | Enrichment | COL2A1 | 2.45 |
| 130 | Blood group, colton system | Enrichment | AQP1 | 2.45 |
| 131 | Fibrochondrogenesis 1 | Enrichment | COL11A1 | 2.45 |
| 132 | Spondyloepiphyseal dysplasia, stanescu type | Enrichment | COL2A1 | 2.45 |
| 133 | Lissencephaly 5 | Enrichment | LAMB1 | 2.45 |
| 134 | Macular dystrophy, retinal, 2 | Enrichment | PROM1 | 2.45 |
| 135 | Steatocystoma multiplex | Enrichment | KRT17 | 2.45 |
| 136 | Acrogeria, gottron type | Enrichment | COL3A1 | 2.45 |
| 137 | Achondrogenesis, type ii | Enrichment | COL2A1 | 2.45 |
| 138 | Helix syndrome | Enrichment | CLDN10 | 2.45 |
| 139 | Nephrotic syndrome, type 26 | Enrichment | LAMA5 | 2.45 |
| 140 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 2 | Enrichment | COL1A2 | 2.45 |
| 141 | Spondyloperipheral dysplasia | Enrichment | COL2A1 | 2.45 |
| 142 | Deafness, autosomal dominant 37 | Enrichment | COL11A1 | 2.45 |
| 143 | Uveal coloboma-cleft lip and palate-intellectual disability | Enrichment | YAP1 | 2.45 |
| 144 | Deafness, autosomal dominant 13 | Enrichment | COL11A2 | 2.45 |
| 145 | Stickler syndrome, type i, nonsyndromic ocular | Enrichment | COL2A1 | 2.45 |
| 146 | Cortical malformations, occipital | Enrichment | LAMC3 | 2.45 |
| 147 | Fibrochondrogenesis 2 | Enrichment | COL11A2 | 2.45 |
| 148 | Retinitis pigmentosa 41 | Enrichment | PROM1 | 2.45 |
| 149 | Bent bone dysplasia syndrome 2 | Enrichment | LAMA5 | 2.45 |
| 150 | Vitreoretinopathy with phalangeal epiphyseal dysplasia | Enrichment | COL2A1 | 2.45 |
| 151 | Asphyxia neonatorum | Enrichment | COL1A1 | 2.45 |
| 152 | Occipital pachygyria and polymicrogyria | Enrichment | LAMC3 | 2.45 |
| 153 | Aquagenic palmoplantar keratoderma | Enrichment | CFTR | 2.45 |
| 154 | Autosomal dominant rhegmatogenous retinal detachment | Enrichment | COL2A1 | 2.45 |
| 155 | Multiple epiphyseal dysplasia with myopia and deafness | Enrichment | COL2A1 | 2.45 |
| 156 | Hypochondrogenesis | Enrichment | COL2A1 | 2.45 |
| 157 | Pneumothorax | Enrichment | COL5A1 | 2.45 |
| 158 | Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome | Enrichment | COL11A1 | 2.45 |
| 159 | Dysspondyloenchondromatosis | Enrichment | COL2A1 | 2.45 |
| 160 | Cystic lymphangioma | Enrichment | COL11A2 | 2.45 |
| 161 | Abdominal aortic aneurysm | Enrichment | COL3A1 | 2.45 |
| 162 | Type 2 collagen-related bone disorder | Enrichment | COL2A1 | 2.45 |
| 163 | Lama5-related multisystemic syndrome | Enrichment | LAMA5 | 2.45 |
| 164 | Laminin subunit alpha 2-related muscular dystrophy | Enrichment | LAMA2 | 2.45 |
| 165 | Lacrimoauriculodentodigital syndrome 1 | Enrichment | FGF10 | 2.40 |
| 166 | Syndactyly, type iv | Enrichment | SHH | 2.40 |
| 167 | Mullerian duct aplasia, unilateral renal agenesis, and cervicothoracic somite anomalies | Enrichment | HNF1B | 2.40 |
| 168 | 46,xx sex reversal 1 | Enrichment | SOX9 | 2.40 |
| 169 | Heart defects, congenital, and other congenital anomalies | Enrichment | GATA6 | 2.40 |
| 170 | Chromosome 17q12 deletion syndrome | Enrichment | HNF1B | 2.40 |
| 171 | Hypoplastic or aplastic tibia with polydactyly | Enrichment | SHH | 2.40 |
| 172 | Chromophobe renal cell carcinoma | Enrichment | HNF1B | 2.40 |
| 173 | Familial vesicoureteral reflux | Enrichment | SOX17 | 2.40 |
| 174 | Lung cancer | Enrichment | ACTA2, EGFR, ERBB2 | 2.39 |
| 175 | Glycine n-methyltransferase deficiency | Enrichment | GNMT | 2.33 |
| 176 | Peroxisome biogenesis disorder 4b | Enrichment | GNMT | 2.33 |
| 177 | Pancreatic agenesis 2 | Enrichment | PTF1A | 2.33 |
| 178 | Trypsinogen deficiency | Enrichment | PRSS1 | 2.33 |
| 179 | Stargardt disease 1 | Enrichment | COL2A1, PROM1 | 2.30 |
| 180 | Lung non-small cell carcinoma | Enrichment | EGFR, ERBB2 | 2.28 |
| 181 | Polydactyly, preaxial ii | Enrichment | SHH | 2.28 |
| 182 | Schizencephaly | Enrichment | SHH | 2.28 |
| 183 | Transposition of the great arteries | Enrichment | GATA4 | 2.28 |
| 184 | Middle aortic syndrome | Enrichment | GATA6 | 2.28 |
| 185 | Ventricular septal defect 1 | Enrichment | GATA4 | 2.18 |
| 186 | Nonsyndromic 46,xx testicular disorders/differences of sex development | Enrichment | SOX9 | 2.18 |
| 187 | Persistent truncus arteriosus | Enrichment | GATA6 | 2.18 |
| 188 | Brown-vialetto-van laere syndrome 2 | Enrichment | GNMT | 2.15 |
| 189 | Ehlers-danlos syndrome, vascular type | Enrichment | COL3A1 | 2.15 |
| 190 | Epiphyseal dysplasia, multiple, 1 | Enrichment | COL1A1 | 2.15 |
| 191 | Amelogenesis imperfecta, type ia | Enrichment | LAMB3 | 2.15 |
| 192 | Ehlers-danlos syndrome, hypermobility type | Enrichment | COL3A1 | 2.15 |
| 193 | Epidermolysis bullosa, junctional 2c, laryngoonychocutaneous | Enrichment | LAMA3 | 2.15 |
| 194 | Bruck syndrome 1 | Enrichment | COL1A2 | 2.15 |
| 195 | Spermatogenic failure, y-linked, 2 | Enrichment | CFTR | 2.15 |
| 196 | Myasthenic syndrome, congenital, 5 | Enrichment | LAMB2 | 2.15 |
| 197 | Dermatofibrosarcoma protuberans | Enrichment | COL1A1 | 2.15 |
| 198 | Legg-calve-perthes disease | Enrichment | COL2A1 | 2.15 |
| 199 | Proximal renal tubular acidosis-ocular anomaly syndrome | Enrichment | SLC4A4 | 2.15 |
| 200 | Lissencephaly 1 | Enrichment | LAMB1 | 2.15 |
| 201 | Pierson syndrome | Enrichment | LAMB2 | 2.15 |
| 202 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 1 | Enrichment | COL1A1 | 2.15 |
| 203 | Epidermolysis bullosa, junctional 3b, severe | Enrichment | LAMC2 | 2.15 |
| 204 | Epidermolysis bullosa, junctional 3a, intermediate | Enrichment | LAMC2 | 2.15 |
| 205 | Fibromuscular dysplasia, multifocal | Enrichment | COL5A1 | 2.15 |
| 206 | Epidermolysis bullosa, junctional 2a, intermediate | Enrichment | LAMA3 | 2.15 |
| 207 | Polymicrogyria with or without vascular-type ehlers-danlos syndrome | Enrichment | COL3A1 | 2.15 |
| 208 | Nephrotic syndrome, type 5, with or without ocular abnormalities | Enrichment | LAMB2 | 2.15 |
| 209 | Osteopetrosis, autosomal recessive 3 | Enrichment | CA2 | 2.15 |
| 210 | Aortic dissection | Enrichment | COL3A1 | 2.15 |
| 211 | Steel syndrome | Enrichment | COL27A1 | 2.15 |
| 212 | Familial avascular necrosis of the femoral head | Enrichment | COL2A1 | 2.15 |
| 213 | Epidermolysis bullosa, junctional 2b, severe | Enrichment | LAMA3 | 2.15 |
| 214 | Autosomal recessive proximal renal tubular acidosis | Enrichment | SLC4A4 | 2.15 |
| 215 | Dentinogenesis imperfecta | Enrichment | COL1A2 | 2.15 |
| 216 | Conotruncal heart malformations | Enrichment | GATA6 | 2.10 |
| 217 | Pierre robin syndrome | Enrichment | SOX9 | 2.10 |
| 218 | Coronary artery anomaly | Enrichment | CELA2A | 2.03 |
| 219 | Lynch syndrome | Enrichment | CFTR, EPCAM | 2.01 |
| 220 | Septopreoptic holoprosencephaly | Enrichment | DLL1, SHH | 2.01 |
| 221 | Midline interhemispheric variant of holoprosencephaly | Enrichment | DLL1, SHH | 2.01 |
| 222 | Ichthyosis hystrix, curth-macklin type | Enrichment | KRT1 | 2.00 |
| 223 | Dermatopathia pigmentosa reticularis | Enrichment | KRT14 | 2.00 |
| 224 | Paget disease, extramammary | Enrichment | ERBB2 | 2.00 |
| 225 | Split-hand/foot malformation 1 with sensorineural hearing loss, autosomal recessive | Enrichment | DLX5 | 2.00 |
| 226 | Palmoplantar keratoderma, nonepidermolytic | Enrichment | KRT1 | 2.00 |
| 227 | Vohwinkel syndrome, variant form | Enrichment | LORICRIN | 2.00 |
| 228 | Naegeli-franceschetti-jadassohn syndrome | Enrichment | KRT14 | 2.00 |
| 229 | Uric acid concentration, serum, quantitative trait locus 1 | Enrichment | ABCG2 | 2.00 |
| 230 | Spinocerebellar ataxia 43 | Enrichment | MME | 2.00 |
| 231 | Deafness, autosomal dominant 2b | Enrichment | GJB3 | 2.00 |
| 232 | Ichthyosis, congenital, autosomal recessive 12 | Enrichment | CASP14 | 2.00 |
| 233 | Visceral neuropathy, familial, 2, autosomal recessive | Enrichment | ERBB2 | 2.00 |
| 234 | Ichthyosis, annular epidermolytic, 2 | Enrichment | KRT1 | 2.00 |
| 235 | Netherton syndrome | Enrichment | SPINK5 | 2.00 |
| 236 | Keratosis palmoplantaris striata iii | Enrichment | KRT1 | 2.00 |
| 237 | Immunodeficiency 46 | Enrichment | TFRC | 2.00 |
| 238 | Lynch syndrome 8 | Enrichment | EPCAM | 2.00 |
| 239 | Blood group, junior system | Enrichment | ABCG2 | 2.00 |
| 240 | Neuropathy with hearing impairment | Enrichment | GJB3 | 2.00 |
| 241 | Congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization | Enrichment | MME | 2.00 |
| 242 | Charcot-marie-tooth disease type 2t | Enrichment | MME | 2.00 |
| 243 | Palmoplantar keratoderma, epidermolytic, 2 | Enrichment | KRT1 | 2.00 |
| 244 | Mme-related autosomal dominant charcot marie tooth disease type 2 | Enrichment | MME | 2.00 |
| 245 | Ichthyosis linearis circumflexa | Enrichment | SPINK5 | 2.00 |
| 246 | Split hand-foot malformation 1 with sensorineural hearing loss | Enrichment | DLX5 | 2.00 |
| 247 | Autosomal recessive epidermolytic ichthyosis | Enrichment | KRT10 | 2.00 |
| 248 | Premature aging | Enrichment | VIM | 2.00 |
| 249 | Serous carcinoma of the corpus uteri | Enrichment | ERBB2 | 2.00 |
| 250 | Permanent neonatal diabetes mellitus | Enrichment | PDX1 | 1.98 |
| 251 | Combined pituitary hormone deficiency | Enrichment | FOXA2 | 1.98 |
| 252 | Mccune-albright syndrome | Enrichment | COL2A1 | 1.98 |
| 253 | Spondyloepiphyseal dysplasia congenita | Enrichment | COL2A1 | 1.98 |
| 254 | Megalocornea | Enrichment | COL11A1 | 1.98 |
| 255 | Nail disorder, nonsyndromic congenital, 4 | Enrichment | KRT17 | 1.98 |
| 256 | Hypophosphatasia, infantile | Enrichment | COL11A2 | 1.98 |
| 257 | Glomerulopathy with fibronectin deposits 2 | Enrichment | FN1 | 1.98 |
| 258 | Nuchal bleb, familial | Enrichment | CFTR | 1.98 |
| 259 | Muscular dystrophy, congenital merosin-deficient, 1a | Enrichment | LAMA2 | 1.98 |
| 260 | Cone-rod dystrophy 12 | Enrichment | PROM1 | 1.98 |
| 261 | Caffey disease | Enrichment | COL1A1 | 1.98 |
| 262 | Poretti-boltshauser syndrome | Enrichment | LAMA1 | 1.98 |
| 263 | Multiple epiphyseal dysplasia | Enrichment | COL2A1 | 1.98 |
| 264 | Lama2-related muscular dystrophy | Enrichment | LAMA2 | 1.98 |
| 265 | Microform holoprosencephaly | Enrichment | DLL1, SHH | 1.96 |
| 266 | Lobar holoprosencephaly | Enrichment | DLL1, SHH | 1.96 |
| 267 | Vitamin d-dependent rickets, type 2a | Enrichment | PRSS1 | 1.93 |
| 268 | Orofacial cleft 1 | Enrichment | FGF10 | 1.93 |
| 269 | Adult hepatocellular carcinoma | Enrichment | EGF | 1.93 |
| 270 | Alobar holoprosencephaly | Enrichment | DLL1, SHH | 1.90 |
| 271 | Semilobar holoprosencephaly | Enrichment | DLL1, SHH | 1.86 |
| 272 | Pachyonychia congenita 1 | Enrichment | KRT17 | 1.85 |
| 273 | Phenylketonuria | Enrichment | COL1A1 | 1.85 |
| 274 | Malignant epithelioid hemangioendothelioma | Enrichment | YAP1 | 1.85 |
| 275 | Idiopathic bronchiectasis | Enrichment | CFTR | 1.85 |
| 276 | 46,xy complete gonadal dysgenesis | Enrichment | SOX9 | 1.84 |
| 277 | Heritable pulmonary arterial hypertension | Enrichment | SOX17 | 1.84 |
| 278 | Hypertelorism | Enrichment | COL11A1, COL1A1 | 1.84 |
| 279 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | COL11A1, COL11A2 | 1.84 |
| 280 | Septooptic dysplasia | Enrichment | SHH | 1.80 |
| 281 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | CFTR, GATA4 | 1.78 |
| 282 | Macs syndrome | Enrichment | ALDH1A3, SHH | 1.77 |
| 283 | Diaphragmatic hernia, congenital | Enrichment | GATA6 | 1.77 |
| 284 | Pulmonary hypertension, primary, 1 | Enrichment | SOX17 | 1.77 |
| 285 | Retinal detachment | Enrichment | COL2A1 | 1.76 |
| 286 | Muscular dystrophy, limb-girdle, autosomal recessive 23 | Enrichment | LAMA2 | 1.76 |
| 287 | Osteopetrosis | Enrichment | CA2 | 1.76 |
| 288 | Familial cerebral saccular aneurysm | Enrichment | COL3A1 | 1.76 |
| 289 | Heart disease | Enrichment | GATA4 | 1.73 |
| 290 | Hereditary retinal dystrophy | Enrichment | COL11A2, COL2A1, LAMA1, PROM1 | 1.72 |
| 291 | Fundus dystrophy | Enrichment | COL11A2, COL2A1, LAMA1, PROM1 | 1.72 |
| 292 | Renal cell carcinoma, nonpapillary | Enrichment | HNF1B | 1.70 |
| 293 | Aortic aneurysm, familial thoracic 4 | Enrichment | MYH11 | 1.70 |
| 294 | Hypoparathyroidism, sensorineural deafness, and renal dysplasia syndrome | Enrichment | GATA3 | 1.70 |
| 295 | Ichthyosis hystrix, lambert type | Enrichment | KRT10 | 1.70 |
| 296 | Ichthyosis vulgaris | Enrichment | FLG | 1.70 |
| 297 | Aortic aneurysm, familial thoracic 2 | Enrichment | ACTA2 | 1.70 |
| 298 | Keratoderma, palmoplantar, with nail dystrophy and hereditary motor-sensory neuropathy | Enrichment | KRT1 | 1.70 |
| 299 | Epidermolysis bullosa simplex 2e, with migratory circinate erythema | Enrichment | KRT5 | 1.70 |
| 300 | Dermatitis, atopic, 2 | Enrichment | FLG | 1.70 |
| 301 | Smooth muscle dysfunction syndrome | Enrichment | ACTA2 | 1.70 |
| 302 | Aortic aneurysm, familial thoracic 6 | Enrichment | ACTA2 | 1.70 |
| 303 | Moyamoya disease 5 | Enrichment | ACTA2 | 1.70 |
| 304 | Diarrhea 5, with tufting enteropathy, congenital | Enrichment | EPCAM | 1.70 |
| 305 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 | Enrichment | MYH11 | 1.70 |
| 306 | Epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal recessive | Enrichment | KRT5 | 1.70 |
| 307 | Epidermolysis bullosa, junctional 5a, intermediate | Enrichment | ITGB4 | 1.70 |
| 308 | Sjogren-larsson syndrome | Enrichment | KRT14 | 1.70 |
| 309 | Epidermolytic hyperkeratosis 2a, autosomal dominant | Enrichment | KRT10 | 1.70 |
| 310 | Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures | Enrichment | DLL1 | 1.70 |
| 311 | Ichthyosis, x-linked | Enrichment | FLG | 1.70 |
| 312 | Microphthalmia, isolated 8 | Enrichment | ALDH1A3 | 1.70 |
| 313 | Cataract 30 | Enrichment | VIM | 1.70 |
| 314 | Dermatitis | Enrichment | FLG | 1.70 |
| 315 | Epidermolytic acanthoma | Enrichment | KRT10 | 1.70 |
| 316 | Visceral myopathy 2 | Enrichment | MYH11 | 1.70 |
| 317 | B-lymphoblastic leukemia/lymphoma with hyperdiploidy | Enrichment | GATA3 | 1.70 |
| 318 | Hypoparathyroidism-deafness-renal disease syndrome | Enrichment | GATA3 | 1.70 |
| 319 | Esotropia | Enrichment | TFAP2A | 1.70 |
| 320 | Charcot-marie-tooth disease, axonal, type 2t | Enrichment | MME | 1.70 |
| 321 | Epidermolysis bullosa simplex 2a, generalized severe | Enrichment | KRT5 | 1.70 |
| 322 | Localized junctional epidermolysis bullosa, non-herlitz type | Enrichment | ITGB4 | 1.70 |
| 323 | Autosomal dominant nonsyndromic deafness | Enrichment | GATA3 | 1.70 |
| 324 | Lens subluxation | Enrichment | TFAP2A | 1.70 |
| 325 | Microphthalmia | Enrichment | ALDH1A3, TFAP2A | 1.69 |
| 326 | Developmental dysplasia of the hip 1 | Enrichment | COL2A1 | 1.68 |
| 327 | Inguinal hernia | Enrichment | COL5A1 | 1.68 |
| 328 | Pain disorder | Enrichment | COL5A1 | 1.68 |
| 329 | Intervertebral disc disease | Enrichment | COL11A1 | 1.61 |
| 330 | Multiple enchondromatosis, maffucci type | Enrichment | COL2A1 | 1.61 |
| 331 | Gastroesophageal reflux | Enrichment | COL5A1 | 1.55 |
| 332 | Spastic paraplegia 4, autosomal dominant | Enrichment | COL3A1 | 1.55 |
| 333 | Leber congenital amaurosis 1 | Enrichment | PROM1 | 1.55 |
| 334 | Orthostatic intolerance | Enrichment | COL5A1 | 1.55 |
| 335 | Congenital muscular dystrophy | Enrichment | LAMA2 | 1.55 |
| 336 | Palmoplantar keratoderma, epidermolytic, 1 | Enrichment | KRT1 | 1.52 |
| 337 | Neonatal nephrocutaneous inflammatory syndrome | Enrichment | EGFR | 1.52 |
| 338 | Epidermolysis bullosa, junctional 6, with pyloric atresia | Enrichment | ITGA6 | 1.52 |
| 339 | Epidermolysis bullosa simplex 2b, generalized intermediate | Enrichment | KRT5 | 1.52 |
| 340 | Epidermolytic hyperkeratosis 2b, autosomal recessive | Enrichment | KRT10 | 1.52 |
| 341 | Keratosis palmoplantaris striata | Enrichment | KRT1 | 1.52 |
| 342 | End stage renal disease | Enrichment | GATA3 | 1.52 |
| 343 | Epidermolysis bullosa simplex 2c, localized | Enrichment | KRT5 | 1.52 |
| 344 | Neonatal inflammatory skin and bowel disease | Enrichment | EGFR | 1.52 |
| 345 | Isolated anophthalmia-microphthalmia syndrome | Enrichment | ALDH1A3 | 1.52 |
| 346 | Tricuspid valve insufficiency | Enrichment | MYH11 | 1.52 |
| 347 | Bronchiectasis with or without elevated sweat chloride 1 | Enrichment | CFTR | 1.50 |
| 348 | Vas deferens, congenital bilateral aplasia of | Enrichment | CFTR | 1.50 |
| 349 | Bladder cancer | Enrichment | EGFR, ERBB2 | 1.46 |
| 350 | Marfan syndrome | Enrichment | COL2A1 | 1.46 |
| 351 | Amelogenesis imperfecta, type ie | Enrichment | LAMB3 | 1.46 |
| 352 | Autism | Enrichment | ALDH1A3, COL11A1, SHH | 1.44 |
| 353 | Hypertension | Enrichment | CELA2A | 1.43 |
| 354 | Prostate cancer | Enrichment | HNF1B | 1.42 |
| 355 | Presynaptic congenital myasthenic syndromes | Enrichment | LAMA5 | 1.42 |
| 356 | Branchiooculofacial syndrome | Enrichment | TFAP2A | 1.40 |
| 357 | Otitis media | Enrichment | SPINK5 | 1.40 |
| 358 | Dowling-degos disease 1 | Enrichment | KRT5 | 1.40 |
| 359 | Deafness, autosomal recessive 1a | Enrichment | GJB3 | 1.40 |
| 360 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 | Enrichment | MYH11 | 1.40 |
| 361 | Dermatitis, atopic | Enrichment | FLG | 1.40 |
| 362 | Autoimmune lymphoproliferative syndrome | Enrichment | ACTA2 | 1.40 |
| 363 | Epidermolysis bullosa simplex 5c, with pyloric atresia | Enrichment | ITGB4 | 1.40 |
| 364 | Barrett esophagus | Enrichment | ERBB2 | 1.40 |
| 365 | Dowling-degos disease | Enrichment | KRT5 | 1.40 |
| 366 | Epidermolytic nevus | Enrichment | KRT10 | 1.40 |
| 367 | Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) | Enrichment | MYH11 | 1.40 |
| 368 | Gjb2-related autosomal recessive nonsyndromic hearing loss | Enrichment | GJB3 | 1.40 |
| 369 | Mitral valve insufficiency | Enrichment | MYH11 | 1.40 |
| 370 | Cutis laxa | Enrichment | COL5A1 | 1.38 |
| 371 | Cakut | Enrichment | HNF1B | 1.35 |
| 372 | Microphthalmia/coloboma 12 | Enrichment | YAP1 | 1.35 |
| 373 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | Enrichment | COL5A1 | 1.35 |
| 374 | Clubfoot | Enrichment | COL5A1 | 1.35 |
| 375 | Amelogenesis imperfecta | Enrichment | LAMB3 | 1.35 |
| 376 | Cataract | Enrichment | COL5A1 | 1.31 |
| 377 | Isolated macular dystrophy | Enrichment | PROM1 | 1.31 |
| 378 | Visceral myopathy 1 | Enrichment | MYH11 | 1.31 |
| 379 | Amblyopia | Enrichment | TFAP2A | 1.31 |
| 380 | Histiocytoid hemangioma | Enrichment | VIM | 1.31 |
| 381 | Aplasia cutis congenita | Enrichment | ITGB4 | 1.31 |
| 382 | Coloboma of macula | Enrichment | YAP1 | 1.29 |
| 383 | Kidney disease | Enrichment | LAMB2 | 1.29 |
| 384 | Creatine phosphokinase, elevated serum | Enrichment | LAMA2 | 1.26 |
| 385 | Isolated elevated serum creatine phosphokinase levels | Enrichment | LAMA2 | 1.26 |
| 386 | Colorectal cancer | Enrichment | EPCAM, ERBB2, SOX9 | 1.24 |
| 387 | Cleft palate, isolated | Enrichment | COL11A1 | 1.23 |
| 388 | Branchiootorenal syndrome 1 | Enrichment | TFAP2A | 1.23 |
| 389 | Cowden syndrome 1 | Enrichment | EGFR | 1.23 |
| 390 | Split-hand/foot malformation 1 | Enrichment | DLX5 | 1.23 |
| 391 | Moyamoya disease 1 | Enrichment | ACTA2 | 1.23 |
| 392 | Intestinal pseudo-obstruction | Enrichment | MYH11 | 1.23 |
| 393 | Lung squamous cell carcinoma | Enrichment | EGFR | 1.23 |
| 394 | Nonsyndromic hearing loss | Enrichment | COL11A2, GJB3 | 1.17 |
| 395 | Squamous cell carcinoma, head and neck | Enrichment | EGFR | 1.16 |
| 396 | Branchiootorenal syndrome | Enrichment | TFAP2A | 1.16 |
| 397 | Paroxysmal dystonia | Enrichment | FLG | 1.16 |
| 398 | Gastric cancer | Enrichment | EPCAM, ERBB2 | 1.16 |
| 399 | Glioma susceptibility 1 | Enrichment | ERBB2 | 1.11 |
| 400 | Isolated split hand-split foot malformation | Enrichment | DLX5 | 1.11 |
| 401 | Ear malformation | Enrichment | COL11A2 | 1.09 |
| 402 | Scoliosis | Enrichment | COL2A1 | 1.09 |
| 403 | Ovarian cancer | Enrichment | EGFR, ERBB2, HNF1B | 1.08 |
| 404 | Colonic benign neoplasm | Enrichment | EPCAM | 1.06 |
| 405 | Dilated cardiomyopathy | Enrichment | GATA6, LAMA2 | 1.06 |
| 406 | Cat eye syndrome | Enrichment | TFAP2A | 1.02 |
| 407 | Cataract 30, multiple types | Enrichment | VIM | 1.02 |
| 408 | Lynch syndrome 1 | Enrichment | EPCAM | 1.02 |
| 409 | Nanophthalmos | Enrichment | ALDH1A3 | 0.98 |
| 410 | Combined immunodeficiency | Enrichment | TFRC | 0.98 |
| 411 | Ichthyosis | Enrichment | FLG | 0.98 |
| 412 | Combined t cell and b cell immunodeficiency | Enrichment | TFRC | 0.98 |
| 413 | Combined t and b cell immunodeficiency | Enrichment | TFRC | 0.98 |
| 414 | Cystic fibrosis | Enrichment | CFTR | 0.97 |
| 415 | Usher syndrome | Enrichment | PROM1 | 0.96 |
| 416 | Male infertility | Enrichment | CFTR | 0.94 |
| 417 | Genetic steroid-resistant nephrotic syndrome | Enrichment | LAMA5 | 0.94 |
| 418 | Epicanthus | Enrichment | TFAP2A | 0.94 |
| 419 | Lip and oral cavity carcinoma | Enrichment | EGFR | 0.94 |
| 420 | Neural tube defects | Enrichment | ITGB1 | 0.91 |
| 421 | Charcot-marie-tooth disease | Enrichment | LAMA2 | 0.87 |
| 422 | Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay | Enrichment | FLG | 0.82 |
| 423 | Gliosarcoma | Enrichment | EGFR | 0.82 |
| 424 | Sensorineural hearing loss | Enrichment | COL11A2 | 0.80 |
| 425 | Giant cell glioblastoma | Enrichment | EGFR | 0.80 |
| 426 | Familial isolated dilated cardiomyopathy | Enrichment | LAMA4 | 0.77 |
| 427 | Arteriovenous malformations of the brain | Enrichment | EGFR | 0.76 |
| 428 | Neuropathy, hereditary motor and sensory, okinawa type | Enrichment | MME | 0.76 |
| 429 | Myeloma, multiple | Enrichment | YAP1 | 0.74 |
| 430 | Tooth agenesis | Enrichment | TGFA | 0.70 |
| 431 | Cone-rod dystrophy 2 | Enrichment | PROM1 | 0.67 |
| 432 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | COL11A2, GJB3 | 0.64 |
| 433 | Rare genetic deafness | Enrichment | COL11A2 | 0.61 |
| 434 | Hirschsprung disease 1 | Enrichment | ERBB2 | 0.59 |
| 435 | Peripheral nervous system disease | Enrichment | MME | 0.56 |
| 436 | Neuropathy | Enrichment | MME | 0.56 |
| 437 | Leber plus disease | Enrichment | PROM1 | 0.54 |
| 438 | Hereditary breast carcinoma | Enrichment | EPCAM | 0.44 |
| 439 | Inherited cancer-predisposing syndrome | Enrichment | EGFR, EPCAM | 0.41 |
| 440 | Autosomal dominant non-syndromic intellectual disability | Enrichment | DLL1 | 0.40 |
| 441 | Retinitis pigmentosa | Enrichment | PROM1 | 0.27 |
| 442 | Breast cancer | Enrichment | EPCAM | 0.27 |
| 443 | Microcephaly | Enrichment | FLG | 0.15 |